Smilow Cancer Center — New Haven, Connecticut

Smilow Cancer Center is a clinical research site located in New Haven, Connecticut, United States 06510.

Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.

Smilow Cancer Center has participated in 10 clinical trials with 3 currently active.

Therapeutic areas: Unresectable Intrahepatic Cholangiocarcinoma, Breast Cancer, Hepatocellular Carcinoma.

Sponsors: Yale University, Genentech, Inc., Gilead Sciences.

Sponsor Feasibility Report

Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Smilow Cancer Center?

Smilow Cancer Center has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Smilow Cancer Center conducted?

Smilow Cancer Center has 10 clinical trials on record, with 3 currently active. Their work covers Unresectable Intrahepatic Cholangiocarcinoma, Breast Cancer, Hepatocellular Carcinoma.

Is Smilow Cancer Center accredited by Crixeo Health?

Yes — Smilow Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Smilow Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.